4,954
Views
20
CrossRef citations to date
0
Altmetric
3rd ICSGAD: Research Paper

Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial

, , , , &
Article: e1361573 | Received 01 Jun 2017, Accepted 26 Jul 2017, Published online: 23 Oct 2017

References

  • Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(1):16-6. https://doi.org/10.1111/jdv.12197. PMID:23802806
  • Berk T, Scheinfeld N. Seborrheic dermatitis. Pharm Therap. 2010;35(6):348-52.
  • Schwartz RA, Janusz CA, Janniger CK. Seborrheicdermatitis: an overview. Am Fam Physician. 2006;74:125-30. PMID:16848386
  • Del Rosso JQ, Kim GK. Seborrheic dermatitis and malasseziaspecies: How are theyrelated? J Clin Aesthet Dermatol. 2009;2:14-7. PMID:20725575
  • Sakuma TH, Maibach HI. Oily Skin: An Overview. Skin Pharmacol Physiol. 2012;25(5):227-35. https://doi.org/10.1159/000338978. PMID:22722766
  • De Angelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL Jr. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Invest Dermatol Symp Proc. 2005;10(3):295-7. https://doi.org/10.1111/j.1087-0024.2005.10119.x
  • Guého-Kellermann E, Boekhout T, Begerow D. Biodiversity, phylogeny and ultra structure. In Boekhout T et al. editors. Malassezia and the Skin. Berlin Heidelberg: Springer Verlag; 2010. p. 117-63. DOI: 10.1007/978-3-642-03616-3.
  • Hay RJ, Midgley G. Introduction: Malassezia yeasts from a historical perspective. In Boekhout T et al. editors. Malassezia and the Skin. Berlin Heidelberg: Springer Verlag; 2010. p. 1-16. DOI: 10.1007/978-3-642-03616-3.
  • Gaitanis G, Velegraki A, Alexopoulos EC, Chasapi V, Tsigonia A, Katsambas A. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa. Br J Dermatol. 2006;154(5):854-9. https://doi.org/10.1111/j.1365-2133.2005.07114.x. PMID:16634886
  • Gaitanis G, Mayser P, Scheynius A, Crameri R. Malassezia yeasts in seborrheicandatopic eczemas. In Boekhout T et al. editors, Malassezia and the Skin. Berlin Heidelberg: Springer Verlag; 2010. p. 201-28. DOI: 10.1007/978-3-642-03616-3.
  • Zoubolis CC. Acne and sebaceous gland function. ClinDermatol. 2004;22:360-6.
  • Orfanus CE, Zouboulis CC. Oralretinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196(1):140-7. https://doi.org/10.1159/000017848. PMID:9557249
  • Geissler SE, Michelsen S, Plewig G. Verylow dose is otretinoinis effective in controlling seborrhea. J Dtsch Dermatol Ges. 2003;1(12):952-8. PMID:16285647
  • Abraham S, Piguet V. An unusual presentation of Malassezia dermatosis. Dermatology. 2006;212(1):4-6. https://doi.org/10.1159/000089014. PMID:16319466
  • Sugita T, Boekhout T, Velegraki A, Guillot J, Hađina S, Cabañes FJ. Epidemiology of Malassezia-Related Skin Diseases. Boekhout T et al. editors, Malassezia and the Skin Science and Clinical Practice. Berlin Heidelberg: Springer Verlag; 2010. p. 201–28. DOI: 10.1007/978-3-642-03616-3.
  • Merseguel KB, Nishikaku AS, Rodrigues AM, Padovan AC, e Ferreira RC, de Azevedo Melo AS, Briones MR, Colombo AL. Geneticdiversity of medically important and emerging Candida species causing in vasiveinfection. BMC Infect Dis. 2015;15:57.https://doi.org/10.1186/s12879-015-0793-3. PMID:25887032
  • Guerrits van denEnde, AHG, de Hoog, GS. Variability and molecular diagnostics of the neurotropicspecies Cladophialophorabantiana. Stud Mycol. 1999;43:151-62.
  • White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomalrna genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols: A guideto methods and applications. San Diego: Academic Press, Inc; 1990. p. 315-22.
  • Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000;38(5):337-41. https://doi.org/10.1080/mmy.38.5.337.341. PMID:11092380
  • Mayser P, Gaitanis G. Physiology and Biochemistry. Boekhout T et al. editors. Malassezia and the Skin. Berlin Heidelberg: Springer Verlag; 2010. p. 121-37. DOI: 10.1007/978-3-642-03616-3.
  • SandströmFalk MH, TengvallLinder M, Johansson C. The prevalence of Malasseziayeasts in patients with at opicdermatitis, seborrhoeicdermatitis and healthy controls. Acta DermVenereol. 2005;85:17-23.
  • Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheicdermatitis. AnBrasDermatol. 2011;86(6):1061-74.
  • Gupta AK, Nicol KA. Ciclopirox 1% shampoo for the treatment of seborrheicdermatitis. Int J Dermatol. 2006;45:66-9. https://doi.org/10.1111/j.1365-4632.2004.02331.x. PMID:16426382
  • Vena GA, Micali G, Santoianni P, et al. Oral terbinafine in the treatment of multi-siteseborrheicdermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005;18:745-53. https://doi.org/10.1177/039463200501800418. PMID:16388724
  • Bailey P, Arrowsmith C, Darling K. A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTOonthescalp vs. antidandruff efficacy and antimycoticactivity. Int J CosmetSci. 2003;25:183-8. https://doi.org/10.1046/j.1467-2494.2003.00183.x
  • Bhatia N. Treating seborrheicdermatitis: review of mechanisms and the rapeuticoptions. J DrugsDermatol. 2013;12(7):796-8.
  • Borgers M, Degreef H. The role of ketoconazole in seborrheicdermatitis. Cutis. 2007;80:359-63. PMID:18038701
  • Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheicdermatitis: a placebo-controlled study. Am J ClinDermatol. 2007;8:235-8.
  • Elewski BE, Abramovits W, Kempers S. A novel foamformulation of ketoconazole 2% for the treatment of seborrheicdermatitis on multiple body regions. J Drugs Dermatol. 2007;6:1001-8. PMID:17966177
  • Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeicdermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol. 2005;19(2):172-5. https://doi.org/10.1111/j.1468-3083.2005.01090.x. PMID:15752285
  • Lodén M, Wessman C. The antidandruff efficacy of a shampoo containing piroctoneolamine and salicylicacid in comparison to that of a zincpyrithione shampoo. Int J CosmetSci. 2000;22:285-9. https://doi.org/10.1046/j.1467-2494.2000.00024.x
  • Ang-Tiu CU, Meghrajani CF, Maano CC. Pimecrolimus 1% cream for the treatment of seborrheicdermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2012;5(1):91-7. https://doi.org/10.1586/ecp.11.68. PMID:22142161
  • Tajima M, Sugita T, Nishikawa A. Molecular analysis of Malassezia microflora in seborrheicdermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol. 2008;128:345-51. https://doi.org/10.1038/sj.jid.5701017. PMID:17671514
  • Gupta AK, Kohli Y. Prevalence of Malassezias pecieson various body sites in clinically healthy subjects representing different age groups. Med Mycol. 2004;42:35-42. https://doi.org/10.1080/13693780310001610056. PMID:14982112
  • Cafarchia C, Gasser RB, Figueredo LA, Latrofa MS, Otranto D. Advances in the identification of Malassezia. Mol Cell Probes. 2011;25(1):1-7. https://doi.org/10.1016/j.mcp.2010.12.003. PMID:21193026
  • Gemmer CM, De Angelis YM, Theelen B, Boekhout T, Dawson TL Jr. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol. 2002;40(9):3350-7.https://doi.org/10.1128/JCM.40.9.3350-3357.2002. PMID:12202578
  • Colombo AL, Padovan ACB, Chaves GM. Current Knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011;24(4):682-700. https://doi.org/10.1128/CMR.00003-11. PMID:21976604
  • Bartell H, Ransdell BL, Ali A. Tinea versicolor clearance with oral isotretinoin therapy. J Drug Dermatol. 2006;5:74-5.
  • Kamamoto CSL, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea/seborrheic dermatitis: a randomized and comparative trial. Int J Dermatol. 2017;56:80-5. https://doi.org/10.1111/ijd.13408. PMID:27778328
  • Zoubolis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006;126:2154-6. https://doi.org/10.1038/sj.jid.5700418. PMID:16983322
  • Berk DR. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study: comment. Br J Dermatol. 2011;165(1):205.https://doi.org/10.1111/j.1365-2133.2011.10305.x. PMID:21410669
  • Lee JW, Yoo KH, Park KY, Han TY, Li K, Seo SJ, Hong CK. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol. 2011;164(6):1369-75. https://doi.org/10.1111/j.1365-2133.2010.10152.x. PMID:21114478
  • Bagatin E, Guadanhim LR, Enokihara MM, Sanudo A, Talarico S, Miot HA, Gibson L. Low-dose oral isotretinoin versus topical retinoic acid for photoaging: a randomized, comparative study. Int J Dermatol. 2014;53:14-22. https://doi.org/10.1111/ijd.12191
  • Emre S, Metin A, Demirseren DD, Akoglu G, Oztekin A, Neselioglu S, Erel O. The association of oxidative stress and disease activity in seborrheic dermatitis. Arch Dermatol Res. 2012;304(9):683-7. https://doi.org/10.1007/s00403-012-1254-0. PMID:22699428